SpeechPathology.com Phone: 800-242-5183

New master brand. Same great company. Introducing continued! Read Our Story

Progressus Therapy

Speech Therapy for Patients with Myasthenia Gravis

Patrick Coppens, Ph.D

October 8, 2007



What should be the main focus of speech and language therapy for patients with myasthenia gravis?


Individuals with myasthenia gravis have a disorder at the level of the neuromuscular junction, where the acetylcholine neurotransmitter is unable to sustain its activity on the receptors in the muscles. Consequently, patients are able to perform all movements for a while, but are unable to sustain the activity for an extended period of time. Essentially, muscles fatigue.

Individuals with myasthenia gravis have motor speech difficulties, specifically flaccid dysarthria, but no language disorders. With use, articulation becomes increasingly imprecise, hypernasality increases, etc. The assessment should include stress testing to show decrease of articulatory precision with use.

These patients are usually on anticholinesterase medications which help significantly. In most cases, speech pathologists focus on environmental modifications and AAC. The patient is asked to take multiple periods of rest and to avoid prolonged use of the articulatory musculature. Also, the SLP assesses and recommends an appropriate AAC device tailored to the patient's needs and preferences. This allows the patient to keep communicating during periods of rest or when speech becomes unintelligible. Because of intact language and cognition, a high tech AAC device is usually appropriate.

Patrick Coppens, Ph.D. is Professor and Chair of Communication Disorders and Sciences and Neurogenics Instructor at Plattsburgh State University of New York.

Related Courses

Visual Supports and Dementia: Facilitating Interaction and Participation
Presented by Kristin Whitfield, MA, CCC-SLP


Kristin Whitfield, MA, CCC-SLP
Course: #6985 1 Hour
  'good examples! LOVED how they did a small little recap in the bottom of a lot of slides'   Read Reviews
People with dementia experience difficulties with memory, communication, and participation in everyday activities. When these same characteristics are seen in individuals with different diagnoses (e.g., Autism, Cerebral Palsy, Aphasia, Traumatic Brain Injury, and ALS) professionals are quick to consider the use of visual supports. This course will provide SLPs with both the research base and practical examples for introducing many forms of visual support to their clients with dementia.

Vanderbilt SLP Journal Club: Managing Communication Deficits in Amyotrophic Lateral Sclerosis
Presented by Sarah Whyte, MS, CCC-SLP


Sarah Whyte, MS, CCC-SLP
Course: #7612 1 Hour
  'Good information regarding needs of the ALS patient at different times in the course of the disease process'   Read Reviews
This course will provide information on the role of the SLP in the management of communication deficits in individuals with amyotrophic lateral sclerosis (ALS), and how those deficits correspond with speech production decline and defined stages of augmentative/alternative communication (AAC) and assistive technology (AT) intervention. This course is open captioned.

ALS: A Clinical Population with Unique Communication Management and AAC Needs, Part 1
Presented by Kim Winter, MA, CCC-SLP


Kim Winter, MA, CCC-SLP
Course: #7782 1 Hour
  'Presenter educated and passionate about subject!'   Read Reviews
This course will provide an overview of the various communication and augmentative/alternative communication (AAC) considerations necessary when working with individuals who have amyotrophic lateral sclerosis (ALS), from the onset of the diagnosis to the end stages of the disease process.

ALS: A Clinical Population with Unique Communication Management and AAC Needs, Part 2
Presented by Kim Winter, MA, CCC-SLP


Kim Winter, MA, CCC-SLP
Course: #7786 1 Hour
  'Great review of practical material'   Read Reviews
This is Part 2 of a two-part series. This course will describe the cognitive impairments associated with amyotrophic lateral sclerosis (ALS) as well as physical functioning, and their impact on augmentative/alternative communication (AAC) selection. Medicare and funding considerations for procuring speech generating devices for this population will also be addressed.

Clinical Uses of the Cognitive Linguistic Quick Test
Presented by Nancy Helm-Estabrooks, Sc.D, CCC-SLP


Nancy Helm-Estabrooks, Sc.D, CCC-SLP
Course: #332 1 Hour
  'Well-supports by evidence'   Read Reviews
During this one-hour on-line course, Dr. Nancy Helm-Estabrooks will discuss clinical uses of the Cognitive Linguistic Quick Test (CLQT). The lecture will be divided into two major areas for discussion of CLQT applications: the CLQT as an assessment/diagnostic instrument, and the CLQT as a tool for forming treatment decisions. Among the clinical populations addressed will be those with right and left hemisphere strokes, traumatic brain injury, Alzheimer's and Parkinson's disease, and mild cognitive impairment. Both research and clinical evidence that support the utility of the CLQT will be reviewed.